Occupational kidney disease among Chinese herbalists exposed to herbs containing aristolochic acids

Occupational and Environmental Medicine

Volumn 68, Issue 4, 2011, Pages 286-290

  Yang, Hsiao Yu ^a,b,c   Wang, Jung Der ^c,d   Lo, Tsai Chang ^e   Chen, Pau Chung ^c,d  

^a BUDDHIST TZU CHI GENERAL HOSPITAL   (Taiwan)

^b TZU CHI UNIVERSITY   (Taiwan)

^c NATIONAL TAIWAN UNIVERSITY   (Taiwan)

^d NATIONAL TAIWAN UNIVERSITY HOSPITAL   (Taiwan)

^e Public Health Bureau   (Taiwan)

Author keywords

[No Author keywords available]

Indexed keywords

ARISTOLOCHIC ACID;

ADULT; AGED; ARTICLE; CHINESE HERB; CHRONIC KIDNEY FAILURE; CONTROLLED STUDY; FEMALE; HEALTH SURVEY; HERBAL MEDICINE; HUMAN; KIDNEY DISEASE; LIFESTYLE; MALE; NEPHROTOXICITY; OCCUPATIONAL CARCINOGENESIS; OCCUPATIONAL DISEASE; OCCUPATIONAL EXPOSURE; OCCUPATIONAL HAZARD; PRIORITY JOURNAL; RISK ASSESSMENT; STRUCTURED QUESTIONNAIRE; WORKER;

ADULT; AGED; ARISTOLOCHIC ACIDS; CASE-CONTROL STUDIES; DRUG COMPOUNDING; DRUG CONTAMINATION; DRUGS, CHINESE HERBAL; FEMALE; HUMANS; KIDNEY FAILURE, CHRONIC; LIFE STYLE; MALE; MEDICINE, CHINESE TRADITIONAL; MIDDLE AGED; OCCUPATIONAL DISEASES; OCCUPATIONAL EXPOSURE; RISK FACTORS; TAIWAN; UREMIA;

EID: 79952574878     PISSN: 13510711     EISSN: 14707926     Source Type: Journal    
DOI: 10.1136/oem.2010.058594     Document Type: Article

References (39)

1. Vanherweghem JL, Depierreux M, Tielemans C, et al. Rapidly progressive interstitial renal fibrosis in young women: association with slimming regimen including Chinese herbs. Lancet 1993;341:387-91. (Pubitemid 23048140)
2. Cosyns JP. Aristolochic acid and 'Chinese herbs nephropathy': a review of the evidence to date. Drug Saf 2003;26:33-48.
3. Debelle FD, Vanherweghem JL, Nortier JL. Aristolochic acid nephropathy: a worldwide problem. Kidney Int 2008;74:158-69. (Pubitemid 351915079)
4. International Agency for Research on Cancer. IARC monographs on the evaluation of carcinogenic risks to humans volume 82 (2002): some traditional herbal medicines, some mycotoxins, naphthalene and styrene. http://monographs. iarc.fr/ENG/Monographs/vol82/index.php (accessed Sep 27, 2010).
5. Au AM, Ko R, Boo FO, et al. Screening methods for drugs and heavy metals in Chinese patent medicines. Bull Environ Contam Toxicol 2000;65:112-19.
6. Li XB, Xing NZ, Wang Y, et al. Transitional cell carcinoma in renal transplant recipients: a single center experience. Int J Urol 2008;15:53-7.
7. Liu SH, Liu YF, Liou SH, et al. Mortality and cancer incidence among physicians of traditional Chinese medicine: a 20-year national follow-up study. Occup Environ Med 2010;67:166-9.
8. Chang HC, Tsai KH. Characteristics of Chinese herbalists in Taiwan (in Chinese). Disquisitions on the Past and Present 2004;11:96-114.
9. Chi C, Lee JL, Lai JS, et al. The practice of Chinese medicine in Taiwan. Soc Sci Med 1996;43:1329-48. (Pubitemid 26358578)
10. Yang HY, Wang JD, Lo TC, et al. Increased mortality risk for cancers of the kidney and other urinary organs among Chinese herbalists. J Epidemiol 2009;19:17-23.
11. Yang HY, Wang JD, Lo TC, et al. Increased risks of upper tract urothelial carcinoma in male and female Chinese herbalists. J Formos Med Assoc In Press.
12. Lu JF, Hsiao WC. Does universal health insurance make health care unaffordable? Lessons from Taiwan. Health Aff (Millwood) 2003;22:77-88. (Pubitemid 41388746)
13. Depierreux M, Van Damme B, Vanden Houte K, et al. Pathologic aspects of a newly described nephropathy related to the prolonged use of Chinese herbs. Am J Kidney Dis 1994;24:172-80. (Pubitemid 24249054)
14. Nortier JL, Vanherweghem JL. Renal interstitial fibrosis and urothelial carcinoma associated with the use of a Chinese herb (Aristolochia fangchi). Toxicology 2002;181-182:577-80. (Pubitemid 36015754)
15. Wu KM, Farrelly JG, Upton R, et al. Complexities of the herbal nomenclature system in traditional Chinese medicine (TCM): lessons learned from the misuse of Aristolochia-related species and the importance of the pharmaceutical name during botanical drug product development. Phytomedicine 2007;14:273-9. (Pubitemid 46386394)
16. Jong TT, Lee MR, Hsiao SS, et al. Analysis of aristolochic acid in nine sources of Xixin, a traditional Chinese medicine, by liquid chromatography/ atmospheric pressure chemical ionization/tandem mass spectrometry. J Pharm Biomed Anal 2003;33:831-7.
17. Drew AK, Whyte IM, Bensoussan A, et al. Chinese herbal medicine toxicology database: monograph on Herba Asari, "xi xin". J Toxicol Clin Toxicol 2002;40:169-72.
18. Cheung TP, Xue C, Leung K, et al. Aristolochic acids detected in some raw Chinese medicinal herbs and manufactured herbal productsea consequence of inappropriate nomenclature and imprecise labelling? Clin Toxicol (Phila) 2006;44:371-8.
19. Tung CF, Ho YL, Tsai HY, et al. Studies on the commonly misused and adulterated Chinese crude drug species in Taiwan (In Chinese). Chin Med Coll J 1999;8:35-46.
20. Lai MN, Lai JN, Chen PC, et al. Increased risks of chronic kidney disease associated with prescribed Chinese herbal products suspected to contain aristolochic acid. Nephrology (Carlton) 2009;14:227-34.
21. Lemy A, Wissing KM, Rorive S, et al. Late onset of bladder urothelial carcinoma after kidney transplantation for end-stage aristolochic acid nephropathy: a case series with 15-year follow-up. Am J Kidney Dis 2008;51:471-7. (Pubitemid 351273477)
22. Cosyns JP, Jadoul M, Squifflet JP, et al. Urothelial lesions in Chinese-herb nephropathy. Am J Kidney Dis 1999;33:1011-17. (Pubitemid 29252669)
23. Chernozemsky IN, Stoyanov IS, Petkova-Bocharova TK, et al. Geographic correlation between the occurrence of endemic nephropathy and urinary tract tumours in vratza district, Bulgaria. Int J Cancer 1977;19:1-11. (Pubitemid 8016919)
24. Dragicevic D, Djokic M, Pekmezovic T, et al. Survival of patients with transitional cell carcinoma of the ureter and renal pelvis in Balkan endemic nephropathy and non-ndemic areas of Serbia. BJU Int 2007;99:1357-62. (Pubitemid 47164802)
25. Djokic M, Hadzi-Djokic J, Nikolic J, et al. Comparison of upper urinary tract tumors in the region of Balkan nephropathy with those of other regions of Yugoslavia. Prog Urol 1999;9:61-8.
26. Miletić-Medved M, Domijan A-M, Peraica M. Recent data on endemic nephropathy and related urothelial tumors in Croatia. Wien Klin Wochenschr 2005;117:604-9. (Pubitemid 41432894)
27. Eknoyan G. Current status of chronic analgesic and nonsteroidal anti-inflammatory drug nephropathy. Curr Opin Nephrol Hypertens 1994;3:182-8.
28. Meliker JR, Wahl RL, Cameron LL, et al. Arsenic in drinking water and cerebrovascular disease, diabetes mellitus, and kidney disease in Michigan: a standardized mortality ratio analysis. Environ Health 2007;6:4.
29. Chiou HY, Chiou ST, Hsu YH, et al. Incidence of transitional cell carcinoma and arsenic in drinking water: a follow-up study of 8,102 residents in an arseniasisendemic area in northeastern Taiwan. Am J Epidemiol 2001;153:411-18.
30. Chen CJ, Hsu LI, Wang CH, et al. Biomarkers of exposure, effect, and susceptibility of arsenic-induced health hazards in Taiwan. Toxicol Appl Pharmacol 2005;206:198-206.
31. Cheng TJ, Wong RH, Lin YP, et al. Chinese herbal medicine, sibship, and blood lead in children. Occup Environ Med 1998;55:573-6.
32. Koh HL, Woo SO. Chinese proprietary medicine in Singapore: regulatory control of toxic heavy metals and undeclared drugs. Drug Saf 2000;23:351-62.
33. Wu TN, Yang KC, Wang CM, et al. Lead poisoning caused by contaminated Cordyceps, a Chinese herbal medicine: two case reports. Sci Total Environ 1996;182:193-5.
34. Ernst E, Thompson Coon J. Heavy metals in traditional Chinese medicines: a systematic review. Clin Pharmacol Ther 2001;70:497-504. (Pubitemid 34008406)
35. Lee CH, Wang JD, Chen PC. Case-crossover study of hospitalization for acute hepatitis in Chinese herb users. J Gastroenterol Hepatol 2008;23:1549-55.
36. Chuang CH, Doyle P, Wang JD, et al. Herbal medicines used during the first trimester and major congenital malformations: an analysis of data from a pregnancy cohort study. Drug Saf 2006;29:537-48.
37. Chung V, Wong E, Woo J, et al. Use of traditional Chinese medicine in the Hong Kong special administrative region of China. J Altern Complement Med 2007;13:361-7. (Pubitemid 46676782)
38. Chuang CH, Hsieh WS, Guo YL, et al. Chinese herbal medicines used in pregnancy: a population-based survey in Taiwan. Pharmacoepidemiol Drug Saf 2007;16:464-8. (Pubitemid 46656868)
39. Cui Y, Shu XO, Gao Y, et al. Use of complementary and alternative medicine by Chinese women with breast cancer. Breast Cancer Res Treat 2004;85:263-70. (Pubitemid 38987261)